Stock screener
Filter the covered US universe by sector, size, profitability, dividends and performance. Every screen has its own shareable link — the address bar reflects your filters.
Showing 541–570 of 574 companies · sorted by market cap (low to high)
| Ticker | Company | Sector | Price | Market cap | P/E | Rev growth | Net margin | Div yield | 1y return |
|---|---|---|---|---|---|---|---|---|---|
| WAT | Waters Corporation | Health Care | $382.41 | $36.9B | 82.1 | +26.4% | +11.9% | n/a | +29.4% |
| NTRA | Natera | Health Care | $264.69 | $37.8B | n/a | +36.6% | -9.1% | n/a | +92.1% |
| A | Agilent Technologies | Health Care | $139.74 | $39.2B | 27.7 | +9.1% | +19.6% | +0.8% | +17.0% |
| RVMD | Revolution Medicines | Health Care | $188.75 | $40.2B | n/a | n/a | -2833.9% | n/a | +402.9% |
| BDX | Becton Dickinson | Health Care | $152.97 | $42.2B | 37.1 | +2.4% | +5.3% | +2.7% | +6.6% |
| IDXX | Idexx Laboratories | Health Care | $539.37 | $42.5B | 38.8 | +13.1% | +24.6% | n/a | +2.4% |
| HUM | Humana | Health Care | $394.50 | $47.2B | 41.7 | +14.1% | +0.8% | +0.9% | +72.0% |
| EW | Edwards Lifesciences | Health Care | $83.82 | $47.9B | 43.7 | +13.8% | +17.4% | n/a | +10.6% |
| MDLN | Medline Inc. | Health Care | $37.63 | $49.5B | 51.2 | +10.7% | +3.3% | n/a | -10.4% |
| CAH | Cardinal Health | Health Care | $225.98 | $52.4B | 33.7 | +12.9% | +0.6% | +0.9% | +43.2% |
| COR | Cencora | Health Care | $305.06 | $59.1B | 23.2 | +6.0% | +0.8% | +0.8% | +4.0% |
| BSX | Boston Scientific | Health Care | $43.58 | $64.3B | 18.0 | +17.4% | +17.3% | n/a | -59.6% |
| REGN | Regeneron Pharmaceuticals | Health Care | $651.91 | $67.4B | 15.2 | +5.9% | +29.6% | +0.6% | +13.9% |
| CI | Cigna | Health Care | $286.29 | $75.3B | 12.0 | +8.8% | +2.3% | +2.2% | -5.1% |
| ELV | Elevance Health | Health Care | $379.31 | $83.3B | 16.8 | +6.3% | +2.5% | +1.8% | +38.1% |
| HCA | HCA Healthcare | Health Care | $376.50 | $83.5B | 12.3 | +6.7% | +8.9% | +0.8% | +6.0% |
| MCK | McKesson Corporation | Health Care | $824.49 | $96.0B | 20.2 | +12.4% | +1.2% | +0.5% | +15.5% |
| MDT | Medtronic | Health Care | $82.01 | $104.6B | 21.8 | +8.4% | +13.2% | +3.5% | -10.9% |
| ISRG | Intuitive Surgical | Health Care | $332.02 | $117.3B | 37.4 | +20.7% | +28.4% | n/a | -33.9% |
| VRTX | Vertex Pharmaceuticals | Health Care | $473.09 | $119.3B | 27.5 | +10.1% | +35.5% | n/a | -0.8% |
| SYK | Stryker Corporation | Health Care | $318.97 | $120.8B | 36.2 | +8.8% | +13.2% | +1.1% | -20.4% |
| BMY | Bristol Myers Squibb | Health Care | $61.51 | $125.8B | 21.0 | +1.8% | +12.3% | +4.1% | +25.6% |
| DHR | Danaher Corporation | Health Care | $192.50 | $134.0B | 36.3 | +4.0% | +14.9% | +0.9% | -5.7% |
| CVS | CVS Health | Health Care | $106.89 | $136.2B | 46.5 | +7.6% | +0.7% | +2.5% | +72.8% |
| PFE | Pfizer | Health Care | $25.01 | $142.4B | 19.0 | +1.4% | +11.8% | +6.9% | -1.4% |
| GILD | Gilead Sciences | Health Care | $130.86 | $161.3B | 17.5 | +3.5% | +31.0% | +2.5% | +15.2% |
| ABT | Abbott Laboratories | Health Care | $100.75 | $175.7B | 32.4 | +8.1% | +11.7% | +2.5% | -20.0% |
| AMGN | Amgen | Health Care | $371.50 | $195.9B | 25.1 | +9.1% | +21.0% | +2.8% | +20.1% |
| TMO | Thermo Fisher Scientific | Health Care | $572.32 | $214.1B | 31.3 | +5.4% | +15.2% | +0.4% | +22.6% |
| MRK | Merck & Co. | Health Care | $130.48 | $318.3B | 35.6 | +2.9% | +13.6% | +2.7% | +55.4% |
This is a shareable URL: filters live in the query string — e.g.
/browse?sector=Health+Care, /browse?index=russell2000,
/browse?mktcap=small, /browse?pe_band=under15,
/browse?growth_band=over20, /browse?margin_band=over20,
/browse?div_yield_band=over4, /browse?div_streak=ge10,
/browse?insider=cluster-buy, /browse?holder=blackrock,
/browse?short=elevated.
Combine them, sort with &sort=dividend_yield&dir=desc (or click a column
header), and page with &page=2.
Data: SEC EDGAR (filings) + Finnhub (prices, fundamentals), as of 2026-07-24 close. Prices are delayed daily-close, labelled with their as-of date.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date. Past performance does not indicate future results.